Oncology
For years, Sara worked in a hospital, making care possible for others. Now, after being diagnosed with breast cancer, she was the one in need of care.
Explore end-to-end solutions throughout development — from portfolio optimization and regulatory strategy, to Phase I-IV clinical trials, market access planning, and more.
See solutionsWHAT WE DO
HOW WE DO IT
Utilize our expertise across therapeutic areas, combining innovative trial designs, leading clinical and regulatory expertise, global reach, and a passion for changing patient lives.
See expertiseTherapeutic Expertise
Cross-Therapeutic Expertise
Our experts help you stay at the forefront of the industry - and ahead of change.
See insightsNew Medicines, Novel Insights
Discussions on Diversity
Thinking about joining a clinical trial? Learn the drug development process, what it’s like to participate, how to find a trial, and answers to frequently asked questions.
Learn moreFor years, Sara worked in a hospital, making care possible for others. Now, after being diagnosed with breast cancer, she was the one in need of care.
It took 10 years of treatments for Anisha's IBD to enter remission. But it came back in 2019 — and just as she was about to start treatment, the pandemic hit.
Want to collaborate with us to offer clinical trials at your site? We would welcome the opportunity to discuss.
Learn moreWe are one of the largest CROs in the world, speeding life-changing medicine to market by engaging patients With Heart™. Learn about who we are, what we do, and what we believe.
About ParexelWhat can we help you find today?
By Jackie Vanderpuye-Orgle, Ph.D., VP, Advanced Analytics
By Rito Bergemann, M.D., Ph.D., VP, Health Economics and Outcomes Research
For a thorough understanding of the AI journey in healthcare, and its potential to transform and improve evidence generation and market access, listen to Rito Bergemann, MD, PhD and Jacqueline Vanderpuye-Orgle, MSc, PhD in their HEOR Theater presentation at the ISPOR US event. AI and human intelligence will play an integral part in RWD analysis and HEOR evidence, and they discuss its growing importance for optimized patient access.
Related Insights
Report
New Medicines, Novel Insights: Advancing rare disease drug development
May 22, 2023
Whitepaper
Addressing the Challenges of Artificial Intelligence used for Data Extraction in Systematic Literature Reviews
Mar 15, 2023
Playbook
Are you using real-world evidence?
Feb 1, 2023
Article
How biotechs can strengthen their value story with advanced analytics
Feb 15, 2022
Blog
Highlights from ISMPP Asia Pacific Meeting 2021
Sep 20, 2021
Whitepaper
Optimizing Biosensor-based Trials
Feb 1, 2023
Report
New Medicines, Novel Insights: Accelerating development of cell and gene therapies
May 22, 2023
Blog
Actigraphy advances a patient-first approach: Reduce patient burden — and make the most of valuable data
Oct 15, 2021
Video
Part One: Gaps to fill with diversity and inclusion in clinical trials
Aug 17, 2021
Blog
Capitalizing on sensors in clinical trials
Sep 20, 2021
Article
3 ways to incorporate DE&I in your communications strategy
Sep 29, 2021
Blog
Generative AI and how we can harness its power in clinical development
Sep 26, 2023